Clinical trials
Gastrointestinal Diseases trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2007 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Active, not recruiting | 5 |
| Recruiting | 5 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| InDex Pharmaceuticals | 3 |
| AbbVie | 2 |
| AstraZeneca | 2 |
| Zealand Pharma | 2 |
| Bellus Health Inc. - a GSK company | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Danisco Sweeteners Oy | 1 |
| Eli Lilly and Company | 1 |
| Genentech, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Diseases | 26 |
| Digestive System Diseases | 8 |
| Inflammatory Bowel Diseases | 8 |
| Intestinal Diseases | 8 |
| Colitis, Ulcerative | 6 |
| Gastrointestinal Neoplasms | 6 |
| Colonic Diseases | 5 |
| Digestive System Neoplasms | 5 |
| Intestinal Neoplasms | 5 |
| Neoplasms by Site | 5 |
Trials
Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.